Johns Hopkins Medical Institutions
Max Kates, MD is an Assistant Professor of Urology and Oncology in the Brady Urological Institute at Johns Hopkins Hospital. He is also co-director of the multidisciplinary bladder cancer clinic. Dr. Kates received his undergraduate degree from Wesleyan University in Connecticut, and his medical degree from Mount Sinai School of Medicine in New York. Dr. Kates’ research interest parallel his clinical practice, with an emphasis on novel treatments for cancers of the urinary tract. He has a particular interest in developing novel therapies for bladder cancer, and currently has a provisional patent for a novel intravesical chemotherapy he developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer.
Disclosure information not submitted.
Saturday, May 14, 2022
2:15 PM – 2:25 PM